Request Sample Inquiry
Epilepsy Drugs Market

Epilepsy Drugs Market

Epilepsy Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

181

Base Year:

2023

Date

Aug - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2598

Segments Covered
  • By Seizure Type By Seizure Type Focal Seizures, Generalized Seizures, Non-epileptic Seizures
  • By Drugs Generation By Drugs Generation First Generation Drugs, Second Generation Drugs, Third Generation Drugs
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers
  • By Region By Region North America, Europe, Asia Pacific, Latin America, The Middle-East and Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 14.36 Billion
Revenue 2032Revenue 2032: USD 21.73 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 4.7%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Epilepsy Drugs Market - Segment Analysis
    1. Overview
    2. Global Epilepsy Drugs Market, 2016 - 2028 (USD Million)
    3. Global Epilepsy Drugs Market - by Seizure Type
      1. By Focal Seizures
      2. By Generalized Seizures
      3. By Non-epileptic Seizures
    4. Global Epilepsy Drugs Market - by Drugs Generation
      1. By First Generation Drugs
      2. By Second Generation Drugs
      3. By Third Generation Drugs
    5. Global Epilepsy Drugs Market - by Distribution Channel
      1. By Hospital Pharmacies
      2. By Drug Stores and Retail Pharmacies
      3. By Online Providers
    6. Global Epilepsy Drugs Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Epilepsy Drugs Market - Segment Analysis
    1. Overview
    2. North America Epilepsy Drugs Market, 2016 - 2028 (USD Million)
    3. North America Epilepsy Drugs Market, by Seizure Type
      1. By Focal Seizures
      2. By Generalized Seizures
      3. By Non-epileptic Seizures
    4. North America Epilepsy Drugs Market, by Drugs Generation
      1. By First Generation Drugs
      2. By Second Generation Drugs
      3. By Third Generation Drugs
    5. North America Epilepsy Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Drug Stores and Retail Pharmacies
      3. By Online Providers
    6. North America Epilepsy Drugs Market, by Country
      1. U.S.
        1. U.S. Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. U.S. Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. U.S. Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      2. Canada
        1. Canada Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Canada Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Canada Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      3. Mexico
        1. Mexico Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Mexico Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Mexico Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
  5. Europe Epilepsy Drugs Market - Segment Analysis
    1. Overview
    2. Europe Epilepsy Drugs Market, 2016 - 2028 (USD Million)
    3. Europe Epilepsy Drugs Market, by Seizure Type
      1. By Focal Seizures
      2. By Generalized Seizures
      3. By Non-epileptic Seizures
    4. Europe Epilepsy Drugs Market, by Drugs Generation
      1. By First Generation Drugs
      2. By Second Generation Drugs
      3. By Third Generation Drugs
    5. Europe Epilepsy Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Drug Stores and Retail Pharmacies
      3. By Online Providers
    6. Europe Epilepsy Drugs Market, by Country
      1. Germany
        1. Germany Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Germany Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Germany Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      2. UK
        1. UK Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. UK Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. UK Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      3. France
        1. France Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. France Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. France Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      4. Spain
        1. Spain Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Spain Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Spain Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      5. Italy
        1. Italy Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Italy Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Italy Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      6. BENELUX
        1. BENELUX Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. BENELUX Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. BENELUX Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      7. Rest of Europe
        1. Rest Of Europe Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Rest Of Europe Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Rest Of Europe Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
  6. Asia Pacific Epilepsy Drugs Market - Segment Analysis
    1. Overview
    2. Asia Pacific Epilepsy Drugs Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Epilepsy Drugs Market, by Seizure Type
      1. By Focal Seizures
      2. By Generalized Seizures
      3. By Non-epileptic Seizures
    4. Asia Pacific Epilepsy Drugs Market, by Drugs Generation
      1. By First Generation Drugs
      2. By Second Generation Drugs
      3. By Third Generation Drugs
    5. Asia Pacific Epilepsy Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Drug Stores and Retail Pharmacies
      3. By Online Providers
    6. Asia Pacific Epilepsy Drugs Market, by Country
      1. China
        1. China Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. China Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. China Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      2. Japan
        1. Japan Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Japan Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Japan Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      3. India
        1. India Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. India Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. India Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      4. South Korea
        1. South Korea Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. South Korea Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. South Korea Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      5. South East Asia
        1. South East Asia Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. South East Asia Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. South East Asia Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Rest of Asia Pacific Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Rest of Asia Pacific Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
  7. Latin America Epilepsy Drugs Market - Segment Analysis
    1. Overview
    2. Latin America Epilepsy Drugs Market, 2016 - 2028 (USD Million)
    3. Latin America Epilepsy Drugs Market, by Seizure Type
      1. By Focal Seizures
      2. By Generalized Seizures
      3. By Non-epileptic Seizures
    4. Latin America Epilepsy Drugs Market, by Drugs Generation
      1. By First Generation Drugs
      2. By Second Generation Drugs
      3. By Third Generation Drugs
    5. Latin America Epilepsy Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Drug Stores and Retail Pharmacies
      3. By Online Providers
    6. Latin America Epilepsy Drugs Market, by Country
      1. Brazil
        1. Brazil Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Brazil Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Brazil Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      2. Argentina
        1. Argentina Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Argentina Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Argentina Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      3. Rest of Latin America
        1. Rest of Latin America Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Rest of Latin America Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Rest of Latin America Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
  8. Middle East & Africa Epilepsy Drugs Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Epilepsy Drugs Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Epilepsy Drugs Market, by Seizure Type
      1. By Focal Seizures
      2. By Generalized Seizures
      3. By Non-epileptic Seizures
    4. Middle East & Africa Epilepsy Drugs Market, by Drugs Generation
      1. By First Generation Drugs
      2. By Second Generation Drugs
      3. By Third Generation Drugs
    5. Middle East & Africa Epilepsy Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Drug Stores and Retail Pharmacies
      3. By Online Providers
    6. Middle East & Africa Epilepsy Drugs Market, by Country
      1. GCC Countries
        1. GCC Countries Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. GCC Countries Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. GCC Countries Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      2. South Africa
        1. South Africa Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. South Africa Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. South Africa Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Epilepsy Drugs Market, By Seizure Type
          1. By Focal Seizures
          2. By Generalized Seizures
          3. By Non-epileptic Seizures
        2. Rest of Middle East & Africa Epilepsy Drugs Market, By Drugs Generation
          1. By First Generation Drugs
          2. By Second Generation Drugs
          3. By Third Generation Drugs
        3. Rest of Middle East & Africa Epilepsy Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Drug Stores and Retail Pharmacies
          3. By Online Providers
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Alkem Labs
    2. Amneal Pharmaceuticals
    3. Angelini S.p.a
    4. Bausch Health Companies Inc.
    5. Dr. Reddy's Laboratories Ltd.
    6. Eisai
    7. GlaxoSmithKline Plc
    8. Johnson & Johnson Service Inc.
    9. Novartis AG
    10. Pfizer Inc.
    11. Sanofi S.A.
    12. SK Biopharmaceuticals
    13. Sumitomo Dainippon Pharma Co. Ltd.
    14. Sun Pharmaceutical Industries Ltd.
    15. Sunovion Pharmaceuticals
    16. Teva Pharmaceutical Industries Ltd.
    17. UCB S.A.
    18. Upsher-Smith
    19. and Zogenix
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Epilepsy Drugs valued at USD 14.36 Billion in 2023 and is expected to reach USD 21.73 Billion in 2032 growing at a CAGR of 4.7%.

  • The prominent players in the market are Alkem Labs, Amneal Pharmaceuticals, Angelini S.p.a, Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd., Eisai, GlaxoSmithKline Plc, Johnson & Johnson Service, Inc., Novartis AG, Pfizer, Inc., Sanofi S.A., SK Biopharmaceuticals, Sumitomo Dainippon Pharma Co., Ltd., Sun Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Teva Pharmaceutical Industries Ltd., UCB S.A., Upsher-Smith, and Zogenix.

  • The market is project to grow at a CAGR of 4.7% between 2024 and 2032.

  • The driving factors of the Epilepsy Drugs include

  • North America was the leading regional segment of the Epilepsy Drugs in 2023.